Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00582_DB06335_nanopub.RAr0z5gq7mtChaIpbPwpVoKE0Gj6ycaXT2yfnRdbOFL2o#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00582_DB06335 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00582_DB06335 label "DDI between Voriconazole and Saxagliptin - Voriconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of saxagliptin by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of saxagliptin if voriconazole is initiated, discontinued or dose changed. [drugbank_resource:DB00582_DB06335]" assertion.
- drugbank_resource:DB00582_DB06335 identifier "drugbank_resource:DB00582_DB06335" assertion.
- drugbank_resource:DB00582_DB06335 title "DDI between Voriconazole and Saxagliptin - Voriconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of saxagliptin by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of saxagliptin if voriconazole is initiated, discontinued or dose changed." assertion.
- drugbank:DB00582 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00582_DB06335 assertion.
- drugbank:DB06335 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00582_DB06335 assertion.